Pharmaceutical / Drug Definition :
Binds to beta2-adrenergic receptors on bronchial cell membrane, stimulating the intracellular enzyme adenylate cyclase to convert adenosine triphosphate to cyclic-3′,5′-adenosine monophosphate. This action relaxes smooth muscles, dilates bronchioles, and increases diuresis.
FDA Label Requirements and Exceptions
Levalbuterol Hydrochloride
FDA Import Information
Levalbuterol Hydrochloride
FDA Detentions
Levalbuterol Hydrochloride (Levalbuterol Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Levalbuterol Hydrochloride (Levalbuterol Hydrochloride Suppliers)
- Processors Levalbuterol Hydrochloride
- Repackers Levalbuterol Hydrochloride
- Relabelers Levalbuterol Hydrochloride
- Exporters Levalbuterol Hydrochloride
- Importers Levalbuterol Hydrochloride
For more information about Levalbuterol Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
